The patient purchased more than 500,000 drugs are basically Class B drugs, and Class B drugs, although some in the health insurance catalog, but there is no mandatory hospitals must purchase such drugs. In addition, because some hospitals' performance appraisals for doctors can also make doctors prescribe Medicare drugs as self-financed drugs, but the fundamental problem is that hospitals have not introduced such drugs.
Medicare catalog of drugs hospitals have not
We know that today the country in the health care reform adopted? centralized purchasing of medicines? , which is also aimed at reducing the burden of medication on consumers.
In the medical insurance catalog to have is the national negotiation drug, the so-called national negotiation drug is the national health insurance bureau staff and drug companies to negotiate, centralized purchasing to suppress the price. The hospitals in the drug catalog will first ensure that this part of the national negotiation drugs, and then will introduce the A drugs, and finally the B drugs.
And some of the Class B drugs, there is no clear regulation that hospitals must be fully equipped with such drugs. When it comes to hospitals not having this kind of drugs, then naturally the patients cannot be reimbursed.
Pharmacies are funded by hospitals and need to make a profit
The hospital in the case is the investor in the pharmacy downstairs, and the drugs that the patient pays for out-of-pocket aren't available in the hospital's pharmacy, but are instead available in the pharmacy that it invests in. This scenario is a direct testament to the fact that hospitals can't generate profits by introducing such drugs and allowing patients to make reimbursements. After all, the hospital invested in the pharmacy to make money, or it could not have wasted manpower and financial resources to open this pharmacy.
But making money should also be divided into circumstances, to engage in rubbish, drilling loopholes in the way to make money will cause more and more patients dissatisfaction!
Medicare applicability limitations, how to accurately define
Medicare in the drug is not a doctor to prescribe the patient can be reimbursed, some are applicable.
For example, the case of the patient's father is the need to use albumin-based drugs, and many of these drugs have a scope of application. For example, the scope of albumin requires that the body's albumin be less than 30 g/L in order to be reimbursed. This range is often difficult to define, so if a patient needs the drug if their albumin level is higher than 30g/L, then obviously they can't be reimbursed.
The patient in the case was asked to purchase the drug at his own expense even though he described his father's albumin level as below 30g/L, mainly because the hospital did not have this type of drug in its catalog.
Medical reform still has a long way to go, and all parties still need to work hard
Medical reform is a major reform that involves every aspect, and it can't be solved overnight.
In this case, the patient is mainly because the hospital did not introduce albumin-based drugs. But as a hospital needs to make a profit to continue to survive, it needs money to support so many medical staff and to introduce all kinds of equipment, and these costs certainly need to be figured out by the hospital itself.
But we also see that the country is working hard on healthcare reform, and I believe that more and more medicines will be made available to patients in the near future!